SCHEMBL9914293

SCHEMBL9914293

CC[C@H](C)N=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9914203 1.00
SCHEMBL220893 1.00
SCHEMBL7977062 0.83
SCHEMBL13336440 0.79 TRPA1 (0.32)
SCHEMBL1109751 0.79 TRPA1 (0.32)
SCHEMBL7636684 0.79 TRPA1 (0.32)
SCHEMBL4914856 0.78 TRPA1 (0.34)
SCHEMBL6408747 0.77 CYP3A4 (0.40)
SCHEMBL21694690 0.76 TRPA1 (0.33)
SCHEMBL1883811 0.75 TRPA1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104106162-B Active material for negative electrode of nonaqueous secondary battery, negative electrode using same, and nonaqueous secondary battery 三菱化学株式会社 2017-09-01 CN disclosed
CN-102725292-A Imidazopyridine compounds as novel constructs for multi-target kinase inhibition ABBOTT LAB 2012-10-10 CN disclosed
US-8198311-B2 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2012-06-12 US disclosed
US-20100075961-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2010-03-25 US disclosed
WO-2008057857-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-&amp;kappav;B ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed